<VariationArchive VariationID="13625" VariationName="NM_000294.3(PHKG2):c.265dup (p.His89fs)" VariationType="Duplication" Accession="VCV000013625" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2014-05-10" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="28664" VariationID="13625">
      <GeneList>
        <Gene Symbol="PHKG2" FullName="phosphorylase kinase catalytic subunit gamma 2" GeneID="5261" HGNC_ID="HGNC:8931" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="30748425" stop="30761176" display_start="30748425" display_stop="30761176" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="30759619" stop="30772496" display_start="30759619" display_stop="30772496" Strand="+" />
          </Location>
          <OMIM>172471</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000294.3(PHKG2):c.265dup (p.His89fs)</Name>
      <CanonicalSPDI>NC_000016.10:30751270:CCCCC:CCCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>16p11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="30751270" stop="30751271" display_start="30751270" display_stop="30751271" variantLength="1" positionVCF="30751270" referenceAlleleVCF="A" alternateAlleleVCF="AC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="30762591" stop="30762592" display_start="30762591" display_stop="30762592" variantLength="1" positionVCF="30762591" referenceAlleleVCF="A" alternateAlleleVCF="AC" />
      </Location>
      <ProteinChange>H89fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.30751275dup" Assembly="GRCh38">
            <Expression>NC_000016.10:g.30751275dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.30762596dup" Assembly="GRCh37">
            <Expression>NC_000016.9:g.30762596dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016616.2" sequenceAccession="NG_016616" sequenceVersion="2" change="g.7977dup">
            <Expression>NG_016616.2:g.7977dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000294.3" sequenceAccession="NM_000294" sequenceVersion="3" change="c.265dup" MANESelect="true">
            <Expression>NM_000294.3:c.265dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000285.1" sequenceAccession="NP_000285" sequenceVersion="1" change="p.His89fs">
            <Expression>NP_000285.1:p.His89fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001172432.2" sequenceAccession="NM_001172432" sequenceVersion="2" change="c.265dup">
            <Expression>NM_001172432.2:c.265dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001165903.1" sequenceAccession="NP_001165903" sequenceVersion="1" change="p.His89fs">
            <Expression>NP_001165903.1:p.His89fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="172471.0001" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000294.3(PHKG2):c.265dup (p.His89fs) AND Glycogen storage disease IXc" Accession="RCV000014595" Version="27">
        <ClassifiedConditionList TraitSetID="3750">
          <ClassifiedCondition DB="MedGen" ID="C2751643">Glycogen storage disease IXc</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-02-20" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-02-20" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2014-05-10" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17689125</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21646031</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">6962066</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8896567</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3750" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6905" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease IXc</ElementValue>
                <XRef ID="MONDO:0013091" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GSD IXc</ElementValue>
                <XRef Type="MIM" ID="613027" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GSD9C</ElementValue>
                <XRef Type="MIM" ID="613027" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Phosphorylase kinase (PhK) deficiency causing glycogen storage disease type IX (GSD IX) results from deficiency of the enzyme phosphorylase b kinase, which has a major regulatory role in the breakdown of glycogen. The two types of PhK deficiency are liver PhK deficiency (characterized by early childhood onset of hepatomegaly and growth restriction, and often, but not always, fasting ketosis and hypoglycemia) and muscle PhK deficiency, which is considerably rarer (characterized by any of the following: exercise intolerance, myalgia, muscle cramps, myoglobinuria, and progressive muscle weakness). While symptoms and biochemical abnormalities of liver PhK deficiency were thought to improve with age, it is becoming evident that affected individuals need to be monitored for long-term complications such as liver fibrosis and cirrhosis.</Attribute>
                <XRef ID="NBK55061" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18387" />
                <XRef ID="18387" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21634085</ID>
                <ID Source="BookShelf">NBK55061</ID>
              </Citation>
              <XRef ID="264580" DB="Orphanet" />
              <XRef ID="C2751643" DB="MedGen" />
              <XRef ID="MONDO:0013091" DB="MONDO" />
              <XRef Type="MIM" ID="613027" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="34849" SubmissionDate="2014-05-01" DateLastUpdated="2014-05-10" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="172471.0001_GLYCOGEN STORAGE DISEASE IXc" title="PHKG2, 1-BP INS_GLYCOGEN STORAGE DISEASE IXc" />
        <ClinVarAccession Accession="SCV000034849" DateUpdated="2014-05-10" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1996-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a Norwegian girl with autosomal recessive glycogen storage disease IXc (GSD9C; 613027) Sovik et al. (1982), Maichele et al. (1996) identified homozygosity for a 1-bp insertion in codon 89 of the PHKG2 gene; the resultant frameshift (after 22% of the normal length of the reading frame) led to premature termination of the predicted polypeptide after 12 additional amino acids. The parents, who were fourth cousins, and a sister were unaffected. She proband presented at 5 months of age, and again at 3 years, with marked hepatomegaly, generalized muscular hypotonia, growth retardation, elevated serum transaminases, and massive liver glycogenosis. PHK activity was barely detectable in liver; in a muscle biopsy, PHK activity was moderately reduced (35% of controls) but muscle glycogen content was nevertheless low. No liver fibrosis was observed. She attained a normal height of 172 cm at age 18, and menarche was at age 17. The relative size of the liver gradually decreased, and at age 18 serum activities of gamma-glutamyltransferase and alanine aminotransferase were approaching normal ranges. Serum cholesterol was normal, hypoglycemic symptoms were not noted, and body weight was normal.</Attribute>
              <Citation>
                <ID Source="PubMed">6962066</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">8896567</ID>
              </Citation>
              <XRef DB="OMIM" ID="613027" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PHKG2" />
          </GeneList>
          <Name>PHKG2, 1-BP INS</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="172471.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GLYCOGEN STORAGE DISEASE IXc</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8039383" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4648793|MedGen:C2751643" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004354588" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8896567</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17689125</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21646031</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8896567</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.His89Profs*13) in the PHKG2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PHKG2 are known to be pathogenic (PMID: 8896567, 17689125, 21646031). This variant is present in population databases (rs764699954, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with glycogen storage disease (PMID: 8896567). ClinVar contains an entry for this variant (Variation ID: 13625). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PHKG2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.30762591_30762592insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2751643" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8039383" TraitType="Disease" MappingType="XRef" MappingValue="C2751643" MappingRef="MedGen">
        <MedGen CUI="C2751643" Name="Glycogen storage disease IXc" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="34849" TraitType="Disease" MappingType="Name" MappingValue="GLYCOGEN STORAGE DISEASE IXc" MappingRef="Preferred">
        <MedGen CUI="C2751643" Name="Glycogen storage disease IXc" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

